Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BABYLON PUMP & POWER LIMITED Share Issue/Capital Change 2011

Nov 13, 2011

64557_rns_2011-11-13_7db3c11b-3721-4495-8270-a2f461c5c3c3.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

IM
Medical
Limited (“ Company ”)

ABN

47
009
436
908

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

  • 1 +Class of +securities issued or to be issued Fully
    paid
    ordinary
    shares
    and
    options.

  • 2 Number of[+] securities issued or to be Shares

54,500,000
shares issued (if known) or maximum number which may be issued Options
54,500,000
options.

  • 3 Principal terms of the[+] securities (eg, if Fully
    paid
    ordinary
    shares
    and
    options. options, exercise price and expiry date; if partly paid[+] securities, the amount Option
    exercise
    price
    $0.01 outstanding and due dates for payment; if[+] convertible securities, the conversion Expiry
    September
    30,
    2016 price and dates for conversion)

  • See chapter 19 for defined terms.

Appendix 3B Page 1

10472797_1

Appendix 3B New issue announcement

4
Do the+securities rank equally in all
respects from the date of allotment with
an existing+class of quoted+securities?
If the additional securities do not rank
equally, please state:
• the date from which they do
• the extent to which they participate
for the next dividend, (in the case of
a trust, distribution) or interest
payment
• the extent to which they do not rank
equally, other than in relation to the
next dividend, distribution or interest
payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly identify
those assets)
7
Dates of entering+securities into
uncertificated holdings or despatch of
certificates
8
Number and+class of all+securities
quoted on ASX (_including_the
securities in clause 2 if applicable)
Shares will rank equally with existing fully paid
ordinary shares.
Options –no.
Options over unissued shares may only be
exercised in accordance with their terms and
conditions. Upon conversion of the options to
shares, the shares will rank equally with
existing shares.
Shares will rank equally with existing fully paid
ordinary shares.
Options –no.
Options over unissued shares may only be
exercised in accordance with their terms and
conditions. Upon conversion of the options to
shares, the shares will rank equally with
existing shares.
0.5 cents per Share.
Options free attaching
Funding to recapitalize the Company and
provide working capital.
14 November 2011
Number +Class
828,364,092

717,814,136
Fully paid ordinary
shares.
Options
  • See chapter 19 for defined terms.

Appendix 3B Page 2

10472797_1

Appendix 3B New issue announcement

9 Number and+class of all+securities
not quoted on ASX (_including_the
securities in clause 2 if applicable)
Number
+Class
22,845,603 options
69,935,559 options
60,000 options
60,000 options
60,000 options
52,000 options
59,891 options
100,000 options
112,000 options
112,000 options
18,100 options
30,800 options
120,000 options
56,000 options
40,000 options
80,000 options
80,000 options
40,000 options
60,000 options
160,000 options
80,000 options
80,000 options
80,000 options
80,000 options
80,000 options
80,000 options
$0.1750 lapse 12/8/13
$0.1250 lapse 12/8/13
$0.1395 lapse 18/2/13
$0.1395 lapse 3/3/13
$0.0945 lapse 25/3/13
$0.0990 lapse 13/4/13
$0.1485 lapse 24/11/11
$0.1350 lapse 23/1/12
$0.2925 lapse 30/4/12
$0.2385 lapse 30/4/12
$0.1890 lapse 26/8/12
$0.1620 lapse 29/9/12
$0.1665 lapse 2/11/12
$0.1665 lapse 7/10/12
$0.1400 lapse 2/12/12
$0.1395 lapse 7/12/12
$0.1350 lapse 5/1/13
$0.1350 lapse 14/1/13
$0.1755 lapse 22/1/13
$0.1755 lapse 29/1/13
$0.1170 lapse 3/5/13
$0.1040 lapse 11/5/13
$0.1105 lapse 19/5/13
$0.0925 lapse 26/5/13
$0.0910 lapse 3/6/13
$0.0915 lapse 21/6/13


10
Dividend policy (in the case of a trust,
distribution policy) on the increased
capital (interests)
No change.

Part 2 - Bonus issue or pro rata issue

11
Is security holder approval required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities will be
offered
14
+Class of+securities to which the offer
relates
15
+Record date to determine entitlements
16
Will holdings on different registers (or
subregisters) be aggregated for
calculating entitlements?
  • See chapter 19 for defined terms.

Appendix 3B Page 3

10472797_1

Appendix 3B New issue announcement

17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the entity
has+security holders who will not be
sent new issue documents
Note: Security holders must be told how
their entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing date for receipt of acceptances
or renunciations
  • See chapter 19 for defined terms.

Appendix 3B Page 4

10472797_1

Appendix 3B New issue announcement

20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount of any handling fee payable to
brokers who lodge acceptances or
renunciations on behalf of+security
holders
25
If the issue is contingent on+security
holders’ approval, the date of the
meeting
26
Date entitlement and acceptance form
and prospectus or Product Disclosure
Statement will be sent to persons
entitled
27
If the entity has issued options, and the
terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do+security holders sell their
entitlements_in full_through a broker?
31
How do+security holders sell_part_of
their entitlements through a broker and
accept for the balance?
32
How do+security holders dispose of
their entitlements (except by sale
through a broker)?
N/A
N/A
Patersons Securities Limited

Fee of 6% of gross amount raised under the
offer
Nil
  • See chapter 19 for defined terms.

Appendix 3B Page 5

10472797_1

Appendix 3B New issue announcement

33 +Despatch date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of securities

  • ( tick one )

  • (a)  Securities described in Part 1

  • (b)[All other securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 [If the ][+][securities are ][+][equity securities, the names of the 20 largest holders of the additional ] +securities, and the number and percentage of additional +securities held by those holders

  • 36 [If the ][+][securities are ][+][equity securities, a distribution schedule of the additional ][+][securities ] setting out the number of holders in the categories 1 - 1,000

  • 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

  • See chapter 19 for defined terms.

Appendix 3B Page 6

10472797_1

Appendix 3B New issue announcement

Entities that have ticked box 34(b)

38
Number of securities for which
+quotation is sought
39
Class of+securities for which quotation
is sought
40
Do the+securities rank equally in all
respects from the date of allotment with
an existing+class of quoted+securities?
If the additional securities do not rank
equally, please state:
• the date from which they do
• the extent to which they participate
for the next dividend, (in the case of
a trust, distribution) or interest
payment
• the extent to which they do not rank
equally, other than in relation to the
next dividend, distribution or interest
payment
41
Reason for request for quotation now
Example: In the case of restricted securities,
end of restriction period
(if issued upon conversion of another
security, clearly identify that other
security)
42
Number and+class of all+securities
quoted on ASX (_including_the securities
in clause 38)
Number +Class
  • See chapter 19 for defined terms.

Appendix 3B Page 7

10472797_1

Appendix 3B New issue announcement

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that noone has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the[+] securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:

............................................................ Date: 14 November 2011 (Director/Company secretary)

Print name: Richard Wadley

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 8

10472797_1

BioDiem Ltd

IM Medical Ltd ABN 47 009 436 908

Appendix A

Top 20 Shareholders

Top 20 Shareholders
Name 14/11/11 %
1 Aviemore Cap PL 80,000,000 9.66%
2 Topsfield Pty Ltd 44,500,000 5.37%
3 Nick Conidi PL 31,444,802 3.80%
4 Paterson Grant Thomas 29,494,427 3.56%
5 Manford Michael Frank 28,617,025 3.45%
6 Jasper Hill Res PL 26,639,032 3.22%
7 Hargrave Street PL 25,200,000 3.04%
8 Bahen Mark John & MP 23,580,368 2.85%
9 Tecca PL 22,292,001 2.69%
10 Kingslane PL 20,000,000 2.41%
11 Wylie Alexander Fleming 18,779,115 2.27%
12 Hoppscotch PL 16,693,763 2.02%
13 Cornela PL 16,450,000 1.99%
14 T T Nicholls PL 15,280,010 1.84%
15 Retzos Inv PL 15,000,000 1.81%
16 Rovuma Inv Ltd 14,100,000 1.70%
17 Blu Bone PL 13,751,065 1.66%
18 SCE Super PL 13,696,007 1.65%
19 St Moritz 1985 PL 12,835,207 1.55%
20 Seventy Three PL 10,696,007 1.29%
Sub-total 479,048,829 57.83%
349,315,263 42.17%
Total shares on issue 828,364,092
1-1000 2058 725,246 0.09%
1001-5000 1479 3,905,810 0.47%
5001-10000 556 4,289,078 0.52%
10001-100000 939 30,256,133 3.65%
100001+ 248 789,187,825 95.27%
5280 828,364,092 100.00%
Top 20 Option Holders
1 Aviemore Cap PL 80,000,000 11.14%
2 Topsfield Pty Ltd 44,500,000 6.20%
3 Nick Conidi PL 29,000,000 4.04%
4 Paterson Grant Thomas 28,494,427 3.97%
5 Manford Michael Frank 25,957,450 3.62%
6 Hargrave Street PL 25,200,000 3.51%
7 Jasper Hill Res PL 22,833,456 3.18%
8 Bahen Mark John & MP 20,211,744 2.82%
9 Tecca PL 20,000,000 2.79%
10 Kingslane PL 20,000,000 2.79%
11 Wylie Alexander Fleming 16,119,540 2.25%
12 Hoppscotch PL 15,083,762 2.10%
13 Retzos Inv PL 15,000,000 2.09%
14 Cornela PL 14,100,000 1.96%
15 Rovuma Inv Ltd 14,100,000 1.96%
16 T T Nicholls PL 13,752,009 1.92%
17 Blu Bone PL 12,305,328 1.71%
18 SCE Super PL 12,168,006 1.70%
19 St Moritz 1985 PL 11,001,606 1.53%
20 Greatside Hldgs PL 10,000,000 1.39%
Sub-total 449,827,328 62.67%
267,986,808 32.35%
Total options on issue 717,814,136
1-1000 20 8,500 0.00%
1001-5000 75 222,682 0.03%
5001-10000 50 380,102 0.05%
10001-100000 188 7,106,446 0.99%
100001+ 167 710,096,406 98.92%
500 717,814,136 100.00%